Qtorin 3.9% rapamycin anhydrous GEL
( DrugBank: - / KEGG DRUG: - )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 278 | Huge lymphatic malformation with cervicofacial lesion | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 279 | Huge venous malformation with cervical, oral and pharyngeal diffuse lesion | 1 |
278. Huge lymphatic malformation with cervicofacial lesion
Clinical trials : 32 / Drugs : 32 - (DrugBank : 12) / Drug target genes : 8 - Drug target pathways : 136
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion
Clinical trials : 24 / Drugs : 24 - (DrugBank : 12) / Drug target genes : 6 - Drug target pathways : 132
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|